Medicine and Dentistry
Therapeutic Procedure
100%
Diseases
66%
Symptomatic Treatment
63%
Evaluation Study
50%
Infection
44%
End of Life Care
38%
COVID-19
37%
Methicillin Resistant Staphylococcus Aureus
34%
DeJerine-Sottas Disease
31%
Amyotrophic Lateral Sclerosis
31%
Clinician
30%
Polyneuropathy
30%
Quality of Life
29%
Health Care
27%
Neuromuscular Disease
26%
Primary Health Care
25%
Motivation
23%
Neuropathy
23%
Neurology
22%
Physical Medicine and Rehabilitation
22%
Drug Therapy
22%
Electrodiagnostic Medicine
21%
Inpatient
21%
Randomized Controlled Trial
20%
Antibiotics
20%
Cannabis
19%
Prevalence
19%
Muscular Dystrophy
19%
Malignant Neoplasm
18%
Electrodiagnosis
18%
Public Health
17%
Magnetic Resonance Imaging
16%
Diabetic Nephropathy
16%
Symptoms
16%
Myotonic Dystrophy
16%
Diagnosis
15%
Symptom
15%
Odds Ratio
14%
Health System
14%
Facioscapulohumeral Muscular Dystrophy
14%
Intensive Care Unit
14%
Weakness
14%
Decision Making
14%
Medical Cannabis
13%
Electronic Health Record
13%
Diabetes
13%
Peripheral Neuropathy
13%
Outpatient
12%
Electromyography
12%
Clostridium Difficile Infection
12%
Laboratory Test
11%
Clinical Management
11%
Chronic Pain
11%
Health Care Cost
11%
Genetic Screening
11%
Clinical Research
10%
Skeletal Muscle
10%
Antibiogram
10%
Clinical Trial
10%
Dyspnea
10%
Mental Health
9%
Duchenne Muscular Dystrophy
9%
Wearable Sensor
9%
Spine Malformation
9%
Antiinfective Agent
9%
Skin Biopsy
9%
Nerve Biopsy
9%
Musculoskeletal Disease
9%
Dynamic Contrast-Enhanced MRI
9%
Breast Cancer
9%
Bloodstream Infection
9%
Quality Improvement
9%
Physical Activity
8%
Neuropathic Pain
8%
Advance Directive
8%
Neoadjuvant Chemotherapy
8%
Chronic Disease
8%
Injury
8%
Pediatrics
8%
Pathogen
8%
Limb
8%
Real Time Polymerase Chain Reaction
8%
Traumatic Brain Injury
8%
Health Outcomes
8%
Lung Function
8%
Cohort Effect
8%
Analgesia
7%
Spinal Muscular Atrophy
7%
Retrospective Cohort Study
7%
Clock Drawing Test
7%
Apoplexy
7%
Logistic Regression Analysis
7%
Cohort Analysis
7%
Motor Performance
7%
Treatment Response
7%
Surgery
7%
Intensive Care
7%
Mini-Mental State Examination
7%
Muscle Contractility
6%
Dystrophy
6%
Nursing and Health Professions
Diseases
59%
Palliative Therapy
52%
Quality of Life
47%
Drug Therapy
43%
Infection
40%
Neuromuscular Disease
39%
Clinician
34%
Methicillin-Resistant Staphylococcus Aureus
31%
Chronic Pain
27%
Health Service
27%
Evaluation Study
24%
Inpatient
24%
Amyotrophic Lateral Sclerosis
24%
End of Life Care
23%
Confidence Interval
21%
Malignant Neoplasm
20%
Primary Medical Care
20%
Prevalence
19%
Wearables
19%
Symptom
17%
Nuclear Magnetic Resonance Imaging
17%
Hospital
17%
Logistic Regression Analysis
17%
Intensive Care Unit
17%
Facioscapulohumeral Muscular Dystrophy
17%
Strength
16%
Cohort Analysis
15%
Spinal Cord Injury
15%
Health Care Personnel
15%
Mental Health
14%
Hospice Care
14%
Terminal Disease
13%
Intensive Care
13%
Pain Intensity
13%
Health Outcomes
12%
Practice Guideline
12%
Diagnosis
12%
Odds Ratio
12%
Cognitive Defect
12%
Diabetes Mellitus
12%
General Practitioner
11%
Outpatient
11%
Healthcare System
11%
Mini Mental State Examination
11%
Emergency Ward
10%
Nurse
10%
Injury
10%
Advanced Cancer
10%
Length of Stay
10%
Musculoskeletal Disease
10%
Myotonic Dystrophy
10%
Electronic Health Record
9%
Adverse Drug Reaction
9%
Total Quality Management
9%
Bloodstream Infection
9%
Syndrome
9%
Clostridium Difficile Infection
9%
Urinary Tract Infection
9%
Hereditary Motor Sensory Neuropathy
9%
Clock Drawing Test
9%
Health Care Utilization
9%
Duchenne Muscular Dystrophy
9%
Alzheimer Disease
8%
Infection Rate
8%
Follow up
8%
Hospital Discharge
8%
Neuropathic Pain
8%
Chronic Disease
8%
Hospital Infection
8%
Physiotherapist
7%
Patient Care
7%
Functional Independence Measure
7%
Traumatic Brain Injury
7%
Muscular Dystrophy
7%
Hospital Readmission
7%
Dying
7%
Severe Acute Respiratory Syndrome
7%
Medical Record
7%
Predictive Value
7%
Methicillin Resistant Staphylococcus Aureus Infection
7%
Body Mass
7%
Emergency Care
7%
Electronic Medical Record
7%
Short Form 36
7%
Weakness
7%
Community Hospital
7%
Patient Care
7%
Antimicrobial Stewardship
6%
Real Time Polymerase Chain Reaction
6%
Social Support
6%
Psychological Functioning
6%
Infection Control
6%
Long Term Care
6%
Catheter
6%
Receiver Operating Characteristic
6%
Antidepressant
6%
Angiographic Catheter
6%
Musculoskeletal Pain
6%
Postpoliomyelitis Syndrome
6%
Infection Prevention
6%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
60%
Infection
42%
Amyotrophic Lateral Sclerosis
31%
Cannabis
26%
Methicillin-Resistant Staphylococcus Aureus
20%
Clinical Trial
16%
Prevalence
14%
Medical Cannabis
13%
Infectious Agent
13%
Antibiotics
12%
Pharmacokinetics
11%
Cohort Study
11%
Side Effect
11%
Diabetic Nephropathy
10%
Opiate
9%
Hereditary Motor Sensory Neuropathy
9%
SARS Coronavirus
9%
Mouse
9%
Coronavirinae
9%
Psychotomimetic
9%
Drug Interaction
9%
Carbon Dioxide
9%
Hospital Infection
8%
Pharmacotherapy
8%
Malignant Neoplasm
8%
Neoplasm
8%
Quinolone Derivative
7%
Antibiotic Agent
7%
Community Pharmacy
7%
Mouse Model
7%
Symptom
7%
Ciprofloxacin
7%
Chronic Disease
7%
Chemotherapy
7%
Antidepressant
7%
Nervous System Inflammation
7%
Hemolysin
6%
Antiinfective Agent
6%
Comorbidity
6%
Streptococcus Agalactiae
6%
Breast Cancer
6%
Natural Product
6%
Systemic Mycosis
6%
Randomized Clinical Trial
6%
Diabetes Mellitus
6%
Neuropathic Pain
6%
Chronic Pain
6%
Peptoclostridium difficile
6%
Phosphatase
6%
Quinolone
6%
Clostridium Difficile Infection
6%
Staphylococcus Aureus
6%
Glioma
6%
Modafinil
6%
Myotonic Dystrophy
5%
Antibiotic Resistance
5%
Neuroprotection
5%
Cannabinoid
5%
Infection Rate
5%
Placebo
5%
Amitriptyline
5%
Biological Marker
5%
Toll Like Receptor
5%